Delayed post-operative haemorrhage after carmustine wafer implantation: A case series from two UK centres

British Journal of Neurosurgery

Volumn 28, Issue 4, 2014, Pages 488-494

  Shah, Rahul Surendra ^a   Homapour, Bobak ^a   Casselden, Elizabeth ^b   Barr, James Geoffrey ^b   Grundy, Paul L ^b   Brydon, Howard L ^a  

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Carmustine; Craniotomy; Gliadel; High grade glioma; Post operative haemorrhage

Indexed keywords

CARMUSTINE; DEXAMETHASONE; TEMOZOLOMIDE; ALKYLATING AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CARMUSTINE WAFER IMPLANT; DRUG IMPLANT; FEMALE; GLIOMA; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; UNITED KINGDOM; BRAIN NEOPLASMS; GLIOBLASTOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES;

EID: 84905506955     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2013.861387     Document Type: Article

References (31)

1. Westphal M , Hilt DC , Bortey E , e t al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 2003 ; 5 : 79-88
2. Stupp R , Mason WP , van Den Bent MJ , e t al . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005 ; 352 : 987-96
3. N ICE: Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma (TA121) . http://www. nice.org.uk/nicemedia/live/ 11620/34049/34049.pdf [Accessed 29/04/2013].
4. B rem H , P iantadosi S , B urger P C, e t al . Placebo-controlled trial of safety and effi cacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas . Th e Polymer-brain Tumor Treatment Group. Lancet 1995 ; 345 : 1008-12
5. Sabel M , Giese A . Safety profi le of carmustine wafers in malignant glioma: A review of controlled trials and a decade of clinical experience . Curr Med Res Opin 2008 ; 24 : 3239-57
6. Gutenberg A , Lumenta CB , Braunsdorf WE , et al . Th e combination of carmustine wafers and temozolomide for the treatment of malignant gliomas . A comprehensive review of the rationale and clinical experience. J Neurooncol 2013 ; 113 : 163-74
7. Wong JM , Panchmatia JR , Ziewacz JE , et al . Patterns in neurosurgical adverse events: Intracranial neoplasm surgery. Neurosurg Focus 2012 ; 33 : E16
8. Palmer JD , Sparrow OC , Iannotti F . Postoperative hematoma: A 5-year survey and identifi cation of avoidable risk factors. Neurosurgery 1994 ; 35 : 1061-4 ; discussion 1064-5
9. Taylor WA , Th omas NW , Wellings JA , Bell BA . Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care. J Neurosurg 1995 ; 82 : 48-50
10. C hang S M, P arney I F, M cDermott M , e t al . Perioperative complications and neurological outcomes of fi rst and second craniotomies among patients enrolled in the Glioma Outcome Project . J Neurosurg 2003 ; 98 : 1175-81
11. Menei P , Metellus P , Parot-Schinkel E , e t al . Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: The French experience . Ann Surg Oncol 2010 ; 17 : 1740-6
12. Brem H , Ewend MG , Piantadosi S , et al . Th e safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial . J Neurooncol 1995 ; 26 : 111-23
13. Ko AL , Fink KR , Stelzer KM , Silbergeld DL . Safety and effi cacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma . Surg Neurol Int 2012 ; 3 : 137
14. Duntze J , Litre CF , Eap C , e t al . Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: Prospective, observational, multicenter study on 92 cases . Ann Surg Oncol 2012
15. N oel G , S chott R , F roelich S , e t al . Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas. Int J Radiat Oncol Biol Phys 2012 ; 82 : 749-55
16. De Bonis P , Anile C , Pompucci A , e t al . Safety and effi cacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma. Acta Neurochir (Wien) 2012 ; 154 : 1371-8
17. Salvati M , D Elia A , Frati A , e t al . Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at fi rst diagnosis . J Neurosurg Sci 2011 ; 55 : 1-6
18. Bock HC , Puchner MJ , Lohmann F , e t al . First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: A multicenter experience. Neurosurg Rev 2010 ; 33 : 441-9
19. Attenello FJ , Mukherjee D , Datoo G , et al . Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience . Ann Surg Oncol 2008 ; 15 : 2887-93
20. Gururangan S , Cokgor L , Rich JN , et al. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas . Neuro Oncol 2001 ; 3 : 246-50
21. Kleinberg LR , Weingart J , Burger P , e t al . Clinical course and pathologic fi ndings after Gliadel and radiotherapy for newly diagnosed malignant glioma: Implications for patient management . Cancer Invest 2004 ; 22 : 1-9
22. K unwar S , P rados M D, C hang S M, e t al . Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group . J Clin Oncol 2007 ; 25 : 837-44
23. McGirt MJ , Th an KD , Weingart JD , e t al . Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme . J Neurosurg 2009 ; 110 : 583-8
24. Valtonen S , Timonen U , Toivanen P , e t al . Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study . Neurosurgery 1997 ; 41 : 44-8 ; discussion 48-9
25. Westphal M , Ram Z , Riddle V , Hilt D , Bortey E . Gliadel wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial . Acta Neurochir (Wien) 2006 ; 148 : 269-75 ; discussion 275
26. Barr JG , Grundy PL . Th e eff ects of the NICE Technology Appraisal 121 (Gliadel and temozolomide) on survival in high-grade glioma. Br J Neurosurg 2012 ; 26 : 818-22
27. Giese A , Kucinski T , Knopp U , e t al . Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma . J Neurooncol 2004 ; 66 : 351-60
28. Dyke JP , Sanelli PC , Voss HU , e t al . Monitoring the eff ects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla. J Neurooncol 2007 ; 82 : 103-10
29. Brem H , Tamargo RJ , Olivi A , et al. B iodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain . J Neurosurg 1994 ; 80 : 283-90
30. M cKenna R , A hmad T , T sa o C H, F rischer H . G lutathione reductase defi ciency and platelet dysfunction induced by 1,3- bis(2-chloroethyl)-1- nitrosourea . J Lab Clin Med 1983 ; 102 : 102-15
31. Miglierini P , Bouchekoua M , Rousseau B , e t al . Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Effi cacy and toxicity . Clin Neurol Neurosurg 2012 ; 114 : 1222-5